Clinical trial
An Open-label, Single Dose Study to Evaluate Lemborexant in Milk of Healthy Lactating Women
NCT04890561 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label, Single Dose Study to Evaluate Lemborexant in Milk of Healthy Lactating Women
- Lead sponsor
- Eisai Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 17, 2021
- Completion date
- August 12, 2021
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy volunteers